1. Home
  2. RXO vs NNNN Comparison

RXO vs NNNN Comparison

Compare RXO & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXO
  • NNNN
  • Stock Information
  • Founded
  • RXO 2022
  • NNNN 2021
  • Country
  • RXO United States
  • NNNN Germany
  • Employees
  • RXO N/A
  • NNNN N/A
  • Industry
  • RXO
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • RXO
  • NNNN Health Care
  • Exchange
  • RXO Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • RXO 2.6B
  • NNNN 2.2B
  • IPO Year
  • RXO N/A
  • NNNN 2025
  • Fundamental
  • Price
  • RXO $18.16
  • NNNN $30.99
  • Analyst Decision
  • RXO Hold
  • NNNN
  • Analyst Count
  • RXO 15
  • NNNN 0
  • Target Price
  • RXO $18.08
  • NNNN N/A
  • AVG Volume (30 Days)
  • RXO 2.1M
  • NNNN 82.0K
  • Earning Date
  • RXO 11-06-2025
  • NNNN 10-23-2025
  • Dividend Yield
  • RXO N/A
  • NNNN N/A
  • EPS Growth
  • RXO N/A
  • NNNN N/A
  • EPS
  • RXO N/A
  • NNNN 0.06
  • Revenue
  • RXO $5,559,000,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • RXO $31.23
  • NNNN N/A
  • Revenue Next Year
  • RXO $6.75
  • NNNN N/A
  • P/E Ratio
  • RXO N/A
  • NNNN $566.20
  • Revenue Growth
  • RXO 46.41
  • NNNN 21.95
  • 52 Week Low
  • RXO $12.19
  • NNNN $5.18
  • 52 Week High
  • RXO $31.98
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • RXO 52.09
  • NNNN 35.89
  • Support Level
  • RXO $14.70
  • NNNN $28.13
  • Resistance Level
  • RXO $17.56
  • NNNN $51.33
  • Average True Range (ATR)
  • RXO 0.79
  • NNNN 5.60
  • MACD
  • RXO 0.10
  • NNNN -0.83
  • Stochastic Oscillator
  • RXO 62.54
  • NNNN 21.54

About RXO RXO Inc.

RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: